Maynard Ryan D 4
4 · Cara Therapeutics, Inc. · Filed Feb 12, 2024
Insider Transaction Report
Form 4
Maynard Ryan D
Chief Financial Officer
Transactions
- Sale
Common Stock
2023-02-08$0.53/sh−5,488$2,909→ 8,012 total
Footnotes (1)
- [F1]This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person on September 14, 2023 accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person.